dabrafenib

GSK's phase III study of trametinib and dabrafenib combo shows survival benefit compared to vemurafenib
Pharmabiz
Sat, 07/19/14 - 09:20 am
trametinib
GSK
vemurafenib
dabrafenib
melanoma
Glaxo's Melanoma Drugs Gets FDA Priority Review
PharmaLive
Mon, 09/16/13 - 05:49 pm
melanoma
GSK
FDA
Tafinlar
Mekinist
trametinib
dabrafenib
metastatic melanoma
3 FDA Stories You Missed This Week
Motley Fool
Sat, 06/1/13 - 12:46 pm
Merck
suvorexant
insomnia
sleep aid
hypnotics
Celgene
Abraxane
prostate cancer
Glaxo
Tafinlar
dabrafenib
melanoma
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Fierce Biotech
Wed, 05/29/13 - 04:49 pm
FDA
GSK
melanoma
dabrafenib
trametinib
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Pipeline Progress at Glaxo
Yahoo/Zacks
Tue, 02/5/13 - 10:33 am
GSK
dabrafenib
melanoma
Glaxo Two-Drug Melanoma Combo Slows Cancer in Study
Bloomberg
Sat, 09/29/12 - 11:55 am
GSK
melanoma
dabrafenib
trametinib
Glaxo Files Two Melanoma Drugs For U.S., Europe Approvals
Bloomberg
Fri, 08/3/12 - 11:23 am
melanoma
GSK
trametinib
dabrafenib
Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Bloomberg
Mon, 06/4/12 - 06:02 pm
GSK
melanoma
dabrafenib
trametinib